Fellowship of the Royal Colleges of Surgeons

New study shows that WATS3D increases diagnostic yield of dysplasia in Barrett's esophagus, regardless of segment length

Retrieved on: 
Wednesday, August 2, 2023
Male, ASGE, University, Diagnosis, Barrett's esophagus, American Society for Gastrointestinal Endoscopy, Pathology, Intestinal metaplasia, Gastrointestinal Endoscopy, MBA, University of Rochester Medical Center, Consultant, Nature Reviews Gastroenterology & Hepatology, Gastrointestinal tract, Dysplasia, Hepatology, Patient, Division, Gastroenterology, GIE, Epithelium, Northwell Health, Society, Medical device, Endoscopy, MD, Fellowship of the Royal Colleges of Surgeons

Regardless of segment length, WATS3D is highly effective at increasing the diagnostic yield of intestinal metaplasia and dysplasia.

Key Points: 
  • Regardless of segment length, WATS3D is highly effective at increasing the diagnostic yield of intestinal metaplasia and dysplasia.
  • "WATS3D has previously shown diagnostic effectiveness for patients with known or suspected BE," said the lead author of the study, Dr. Arvind Trindade, Regional Director of Endoscopy, Northwell Health.
  • "This new study focuses on WATS3D performance in short versus long segment esophageal columnar-lined mucosa."
  • The adjunctive and absolute yields of WATS3D were calculated according to the length of the patient's BE segment.

Maryland Bariatric Center at Mercy Earns National Bariatric Surgery Accreditation and Quality Improvement Program Designation

Retrieved on: 
Friday, January 6, 2023
Bariatric surgery, Education, Inner Harbor, American College, Scar, Bypass, Elective surgery, Health, Adjustable gastric band, MBA, Catholic (term), Patient, Accreditation, Metabolism, Weinberg Center, Fellowship of the Royal Colleges of Surgeons, Quality, Weight loss, CNRP, Sister, The Sisters of Mercy, Mercy Hospital, Society, FACS, Dentistry, Medicine, Statista, Mercy

BALTIMORE, Jan. 5, 2023 /PRNewswire-PRWeb/ -- The Maryland Bariatric Center at Mercy has achieved Comprehensive Center accreditation by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery. The MBSAQIP standards ensure that metabolic and bariatric patients receive multidisciplinary medical care, which improves patient outcomes and long-term success.

Key Points: 
  • BALTIMORE, Jan. 5, 2023 /PRNewswire-PRWeb/ -- The Maryland Bariatric Center at Mercy has achieved Comprehensive Center accreditation by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery.
  • The MBSAQIP designation recognizes the Center's commitment to providing high-quality care to patients, said Kuldeep Singh, M.D., FACS, MBA, FASMBS , a Baltimore magazine "Top Doctor" in Bariatric Surgery, and Director of The Maryland Bariatric Center at Mercy.
  • "The decision to undergo bariatric surgery is a significant one in a patient's journey to realize their goal of better health.
  • Surgical weight loss options include Gastric Bypass Surgery (Roux-en-Y Surgery), Gastric Sleeve Surgery (Sleeve Gastrectomy), and Revision Bariatric Surgery (Revise a Previous Bypass, Lap Band or Gastric Sleeve Surgery).

New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement

Retrieved on: 
Tuesday, January 3, 2023
Cystoscopy, OSE, Bladder cancer, BLC, CMS, Death, NMIBC, Patient, Neoplasm, Cell, FACS, Photocure, 3D ultrasound, ASC, American College, Biopsy, Disease, U.S, CIS, Diagnosis, MD, Health, MPH, Oslo Stock Exchange, Prevalence, Recurrence, Cancer, Carcinoma in situ, Urinary bladder, Research, WLC, Fellowship of the Royal Colleges of Surgeons, Medical imaging, Hospital, Health insurance, Pharmaceutical industry, T4, Medicare, MIBC

Clinical and cost metrics for staging and biopsy rates were assessed, with cost inputs based on Medicare reimbursement rates.

Key Points: 
  • Clinical and cost metrics for staging and biopsy rates were assessed, with cost inputs based on Medicare reimbursement rates.
  • In the published clinical and health economic model, use of BLC resulted in the identification of 5 additional NMIBC recurrences compared to white light cystoscopy alone.
  • World J Urol 2009;27:295–300
    Hexvix/Cysview is a drug that preferentially accumulates in cancer cells in the bladder, making them glow bright pink during Blue Light Cystoscopy (BLC®).
  • Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients.

New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement

Retrieved on: 
Tuesday, January 3, 2023
Cystoscopy, OSE, Bladder cancer, BLC, CMS, Death, NMIBC, Patient, Neoplasm, Cell, FACS, Photocure, 3D ultrasound, ASC, American College, Biopsy, Disease, U.S, CIS, Diagnosis, MD, Health, MPH, Oslo Stock Exchange, Prevalence, Recurrence, Cancer, Carcinoma in situ, Urinary bladder, Research, WLC, Fellowship of the Royal Colleges of Surgeons, Medical imaging, Hospital, Health insurance, Pharmaceutical industry, T4, Medicare, MIBC

Clinical and cost metrics for staging and biopsy rates were assessed, with cost inputs based on Medicare reimbursement rates.

Key Points: 
  • Clinical and cost metrics for staging and biopsy rates were assessed, with cost inputs based on Medicare reimbursement rates.
  • In the published clinical and health economic model, use of BLC resulted in the identification of 5 additional NMIBC recurrences compared to white light cystoscopy alone.
  • World J Urol 2009;27:295–300
    Hexvix/Cysview is a drug that preferentially accumulates in cancer cells in the bladder, making them glow bright pink during Blue Light Cystoscopy (BLC®).
  • Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients.

ABM RESPIRATORY CARE ANNOUNCES THE FDA CLEARANCE OF THE BIWAZE CLEAR SYSTEM

Retrieved on: 
Thursday, December 29, 2022
Person-centered therapy, Patient, Disease management, Communication, Food, Journal, Long-term care, American College, ABM, COVID-19, FDA, Health, Fellowship of the Royal Colleges of Surgeons, Atelectasis, Efficacy, OLE, Bronchiectasis, Regulation of tobacco by the U.S. Food and Drug Administration, Hospital, Cystic fibrosis, Pharmaceutical industry

EAGAN, Minn., Dec. 29, 2022 /PRNewswire/ -- ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze® Clear System.

Key Points: 
  • EAGAN, Minn., Dec. 29, 2022 /PRNewswire/ -- ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze® Clear System.
  • BiWaze® Clear can be used to treat both acute and chronic respiratory conditions in the hospital, long-term care and home environments.
  • "We are continuing to expand our portfolio of respiratory care products to help more people with our technologies" said the CEO of ABM Respiratory Care, Vinay Joshi.
  • Founded in 2017, ABM Respiratory Care is dedicated to advancing patient care by developing intelligent, clinically differentiated and innovative respiratory care solutions to help people breathe better inside and outside the hospital.

Our Lady of the Lake Children's Hospital Verified as Capital Region’s First and Only Level II Pediatric Trauma Center

Retrieved on: 
Tuesday, December 6, 2022
San Jose Hospital & Trauma Center, American College of Surgeons, Trauma, Accident, Fellowship of the Royal Colleges of Surgeons, Physician, Level 2, Nursing, Level, Anesthesiology, Emergency medicine, Documentation, Capital, Health, Hospital, Capital region, American College, ACS, Radiology, Injury, Child Life, Neurosurgery, Critical care, Education, Falls, Pediatric emergency medicine, Lake, Pediatrics, Internal medicine, Research, Glen Lake Children's Camp, ATV, Patient, Lake Health, Dentistry, Medicine, Surgeon, MD

BATON ROUGE, LA, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Our Lady of the Lake Children's Hospital has been verified as a Level II pediatric trauma center by the American College of Surgeons (ACS), making it the first and only pediatric trauma center in the Capital Region to receive the prestigious distinction.

Key Points: 
  • BATON ROUGE, LA, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Our Lady of the Lake Children's Hospital has been verified as a Level II pediatric trauma center by the American College of Surgeons (ACS), making it the first and only pediatric trauma center in the Capital Region to receive the prestigious distinction.
  • Only the second in the state to receive this verification, Our Lady of the Lake Children’s Hospital positions itself to be a destination trauma center for Louisiana’s most severe pediatric trauma cases.
  • "As a Level II pediatric trauma center, Our Lady of the Lake Children's Hospital provides the highest care available in the Capital Region for injured children and their families.
  • Our Lady of the Lake Children’s Hospital has been working toward the Level II designation since the hospital opened its doors in 2019.

American Urological Association Announces 2023 Gallagher Health Policy Scholar

Retrieved on: 
Thursday, December 15, 2022
Society, Physician, Student National Medical Association, Columbia University, Reproductive medicine, American College, Outline of health sciences, Public policy, American Urological Association, Carnegie Mellon University, Health policy, Male, Harvard University, Columbia University Irving Medical Center, Research, Mentorship, MPH, Policy, Surgeon, Multimedia, Public health, Fellowship of the Royal Colleges of Surgeons, University, Education, AUA, Medical director, Loyola University, Diversity, Management, Medical device, Medicine, Urology

BALTIMORE, Dec. 15, 2022 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce Denise Asafu-Adjei MD, MPH, has been named the 2023 AUA Gallagher Health Policy Scholar.

Key Points: 
  • BALTIMORE, Dec. 15, 2022 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce Denise Asafu-Adjei MD, MPH, has been named the 2023 AUA Gallagher Health Policy Scholar.
  • The Gallagher Health Policy Scholar Program is a highly competitive, year-long intensive training designed to prepare the next generation of urologists for leadership positions in health policy.
  • "I am prepared and excited to be fully immersed in the health policy work of the AUA as the 2023 Gallagher Scholar," says Dr. Asafu-Adjei.
  • About the American Urological Association:Founded in 1902 and headquartered nearBaltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has more than 24,000 members around the world.

Top NYC Surgeon, Mark Zoland MD, FACS of Core Surgical Speaks at New York Academy of Medicine

Retrieved on: 
Wednesday, December 14, 2022
Groin, NBA, Columbia University, Suite, American College, Cornell University, Diagnosis, NHL, Patient, NFL, Hospital for Special Surgery, Harvard University, MLS, MLB, New York Academy of Medicine, Pelvic pain, Surgeon, Fellowship of the Royal Colleges of Surgeons, Hospital, Weill Cornell Medicine, Medical device, Dentistry

NEW YORK, Dec.14, 2022 /PRNewswire-PRWeb/ -- Recently, the New York Academy of Medicine hosted Dr. Mark Zoland for an informative lecture at the conference "Hip Preservation- 20 years experience." As a specialist in this area, he helped to provide insight and a diagnostic algorithm for medical professionals regarding the causes and treatment of groin and pelvic pain after hip surgery.

Key Points: 
  • NEW YORK, Dec.14, 2022 /PRNewswire-PRWeb/ -- Recently, the New York Academy of Medicine hosted Dr. Mark Zoland for an informative lecture at the conference "Hip Preservation- 20 years experience."
  • Dr. Mark Zoland graduated from Columbia University and earned his medical degree from Cornell University Medical College.
  • Dr. Zoland leads an elite medical team at Core Surgical in New York City and has presented at institutions such as Harvard, Hospital for Special Surgery, Columbia, and Cornell.
  • To schedule a consultation with Dr. Mark Zoland or for more information about Core Surgical, please visit http://www.coresurgicalmd.com or call (212) 628-8771.

Survey: Surgeons Concerned About Impending Cuts to Surgical Care That Will Harm Patient Care Already Affected by Worker Shortages and Inflation

Retrieved on: 
Friday, December 9, 2022
American College, MD, FACS, Anesthesiology, Patient, Quality of life, Surgical Care and Outcomes Assessment Program, Multimedia, Fellowship of the Royal Colleges of Surgeons, MBA, Health insurance, Dentistry, Surgeon, Medicare

"As our population continues to age, more and more seniors depend on Medicare to receive the care they need.

Key Points: 
  • "As our population continues to age, more and more seniors depend on Medicare to receive the care they need.
  • While members report feeling the impact from supply chain issues and inflation, surgeons are also sounding the siren around healthcare worker shortages.
  • Over nine-in-ten (93%) report healthcare worker shortages impacting their ability to provide high quality care over the last year.
  • The Surgical Care Coalition advocates for access to quality surgical care for all Americans.

William R. Wise, MD, is recognized by Continental Who's Who

Retrieved on: 
Thursday, December 8, 2022
Travel, Hospital, American Medical Association, Indian Medical Association, Person, Suite, American College, MD, BPH, Continental, Incontinence, Sunrise Hospital & Medical Center, Patient, Pebble, Exocrine gland, Creighton University School of Medicine, Urethra, Prostate, Family, Pain, ABU, American Board of Commissioners for Foreign Missions, Pelvic organ prolapse, Multimedia, Fellowship of the Royal Colleges of Surgeons, Kidney, Erectile dysfunction, University, Prostate steam treatment, WISE, Prostate cancer, Candidiasis, Hotel, Medicine, Cathedral Rock, Urology

LAS VEGAS, Dec. 8, 2022 /PRNewswire/ -- William R. Wise, MD, is being recognized by Continental Who's Who as a Trusted Health Care Professional for his exemplary medical contributions and his professional excellence at Las Vegas Urology.

Key Points: 
  • LAS VEGAS, Dec. 8, 2022 /PRNewswire/ -- William R. Wise, MD, is being recognized by Continental Who's Who as a Trusted Health Care Professional for his exemplary medical contributions and his professional excellence at Las Vegas Urology.
  • He then completed an internship, surgical residency, and urology residency at the University of Utah Affiliated Hospitals in Salt Lake City.
  • Wise is experienced in treating common and complex urologic issues for people of all genders.
  • Wise was recognized by Pro News Report in 2021 and was the past President of the Las Vegas Urologic Society.